|

HY-2003 (10 mg/ml), BELKYRA and placebo Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Sichuan Huiyu Pharmaceutical Co., Ltd1

Indications

  • Moderate or Severe Submental Fullness1
  • Cancer1

Other1 trial

A Phase I Study of HY-2003 in the Subjects With Excessive Submental Fat Accumulation
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.